27 Apr 2007 PDL BioPharma Advances Nuvion(R) Into Second Pivotal Study in Intravenous Steroid-Refractory Ulcerative Colitis
27 Apr 2007 Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
25 Apr 2007 Y's Therapeutics Completes Enrollment of Phase II Trial in the U.S. With YSPSL for Prevention of Delayed Graft Function in Renal Transplantation
24 Apr 2007 Micromet Achieves Milestone in BiTE(R) Research Collaboration with MedImmune
24 Apr 2007 KaloBios Licenses Humaneering(TM) Technology to Major Pharmaceutical Company
20 Apr 2007 MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE(R) Molecule
19 Apr 2007 Anti-Cancer Agent Avastin(R), Approved in Japan
19 Apr 2007 Viventia Biotech generates novel human anti-cancer antibody, VB1-050, and identifies its novel target
18 Apr 2007 Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer Animal Models
18 Apr 2007 Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
18 Apr 2007 Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
17 Apr 2007 YM BioSciences' Partner Daiichi Sankyo Receives Clearance for Initial Clinical Trial in Japan
17 Apr 2007 Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
17 Apr 2007 Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
13 Apr 2007 Genmab Initiates HuMax-EGFr Combination Study in Non Small Cell Lung Cancer
13 Apr 2007 XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
07 Apr 2007 FDA approves Cangene's HepaGam B(TM) for a second indication; for use in hepatitis B-positive liver transplant recipients
05 Apr 2007 Merck KGaA: Erbitux Meets Primary Endpoint in First-Line Phase III Head and Neck Cancer Study
05 Apr 2007 Merck KGaA: Erbitux Meets Primary Endpoint in First-Line Phase III Head and Neck Cancer Study
05 Apr 2007 Genzyme Files for Expanded Label for Campath(R) as First-Line Treatment for B-CLL Patients
05 Apr 2007 Crucell Announces Start of Rabies Phase I Antibody Cocktail Clinical Study in India four months after launching initial US Trial
05 Apr 2007 AVEO enters into Worldwide License and Development Agreement with Schering-Plough for AV-299, AVEO's Novel Anti-HGF Antibody
05 Apr 2007 Cerimon Pharmaceuticals Initiates ARREST UC-1, a Global Phase 2b Study of Basiliximab in Patients with Steroid-Refractory Ulcerative Colitis
04 Apr 2007 WILEX gives positive update of current pivotal Phase III trial of RENCAREX(R)
04 Apr 2007 Viventia Biotech initiates patient treatment for Vicinium(TM) Phase II bladder cancer trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up